Medical treatments for male and female pattern hair loss

NE Rogers, MR Avram - Journal of the American Academy of Dermatology, 2008 - Elsevier
Male and female pattern hair loss affects a large percentage of the population, and patients
frequently present for treatment of this to their dermatologist. Here we review the many …

Physiology and medical treatments for alopecia

T Tai, A Kochhar - Facial Plastic Surgery Clinics, 2020 - facialplastic.theclinics.com
Androgenetic alopecia (AGA) is the most common hair loss disorder in men and women. In
both sexes, the resulting physical manifestations can reduce self-esteem, impair quality of …

[HTML][HTML] The relevance of serum levels of long chain omega-3 polyunsaturated fatty acids and prostate cancer risk: A meta-analysis

ME Chua, MCD Sio, MC Sorongon… - Canadian Urological …, 2013 - ncbi.nlm.nih.gov
Objective: Our objective was to systematically analyze the evidence for an association
between serum level long chain omega-3 polyunsaturated fatty acid (n-3 PUFA) and …

[HTML][HTML] Association of 5-alpha-reductase inhibitor and prostate cancer incidence and mortality: a meta-analysis

X Hu, YH Wang, ZQ Yang, YX Shao… - … andrology and urology, 2020 - ncbi.nlm.nih.gov
Background 5-Alpha-reductase inhibitors (5-ARIs) have been suggested as potential
chemopreventive agents for prostate cancer (PCa). This study was conducted to evaluate …

5-alpha reductase inhibitors and the risk of prostate cancer mortality in men treated for benign prostatic hyperplasia

LP Wallner, JR DiBello, BH Li, SK Van Den Eeden… - Mayo Clinic …, 2016 - Elsevier
Objective To compare the risk of prostate cancer mortality among men treated with 5-alpha
reductase inhibitors (5-ARIs) with those treated with alpha-adrenergic blockers (ABs) in …

Chemoprevention of prostate cancer

OW Brawley, IM Thompson - Urology, 1994 - Elsevier
Primary prevention of prostate cancer is a relatively new concept. Through large-scale
studies it is possible that we may be able to define better the risk for prostate cancer and …

The use of 5-alpha reductase inhibitors to manage benign prostatic hyperplasia and the risk of all-cause mortality

LP Wallner, JR DiBello, BH Li, SK Van Den Eeden… - Urology, 2018 - Elsevier
Objective To compare the risk of mortality among men treated for benign prostatic
hyperplasia (BPH) with 5 alpha-reductase inhibitors (5ARI) to those treated with alpha …

The utility of 5-α reductase inhibitors in the prevention and diagnosis of prostate cancer

AB Reed, DJ Parekh - Current opinion in urology, 2009 - journals.lww.com
The utility of 5-α reductase inhibitors in the prevention an... : Current Opinion in Urology The
utility of 5-α reductase inhibitors in the prevention and diagnosis of prostate cancer : Current …

Finasteride for prostatic disease: an updated and comprehensive review

C De Nunzio, R Miano, A Trucchi, EF Agrò… - Expert Opinion on …, 2008 - Taylor & Francis
The development and introduction in clinical practice of finasteride, the first potent inhibitor
of steroid 5-α-reductase that inhibits the conversion of testosterone to its active form …

Finasterida: mitos e verdades

D Steiner - RBM rev. bras. med, 2010 - pesquisa.bvsalud.org
Os folículos pilosos sofrem processo de miniaturização progressiva na alopecia
androgenética. Fatores genéticos e andrógenos desempenham um papel fundamental na …